BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

Historical Holders from Q3 2019 to Q4 2024

Symbol
PHGE on NYSE
CUSIP
09090D103
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
25M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
96.9K
Holdings value
$70.7K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-2
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flynn James E 9.99% $11.4M 15.6M Deerfield Management Company, L.P. Feb 27, 2025
Cystic Fibrosis Foundation 9.99% $1.82M 2.49M Cystic Fibrosis Foundation Feb 27, 2025

Institutional Holders of BiomX Inc. - Common Stock, $0.0001 par value per share (PHGE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 96.9K $70.7K -$180K $0.73 1
2024 Q3 301K $307K -$9.57M $1.02 2
2024 Q2 23.2M $7.81M +$3.18M $0.34 11
2024 Q1 13.8M $6.2M +$2.6M $0.45 9
2023 Q4 8.09M $2.26M -$124K $0.28 13
2023 Q3 7.45M $2.62M -$89.9K $0.35 10
2023 Q2 7.71M $2.77M +$508K $0.36 10
2023 Q1 6.33M $1.93M +$60.6K $0.31 13
2022 Q4 6.16M $1.15M -$38.9K $0.19 14
2022 Q3 6.16M $2.09M -$3.3K $0.34 14
2022 Q2 6.18M $4.51M -$860K $0.73 11
2022 Q1 6.62M $12.8M +$118K $1.93 13
2021 Q4 6.56M $10.5M -$754K $1.60 13
2021 Q3 6.95M $21.3M +$2.59M $3.06 18
2021 Q2 6.09M $33.3M -$587K $5.46 14
2021 Q1 6.18M $44M -$200K $7.12 14
2020 Q4 4.14M $26.4M +$241K $6.38 9
2020 Q3 6.22M $39.5M +$657K $6.34 10
2020 Q2 6.12M $33.8M +$407K $5.51 12
2020 Q1 6.04M $42.2M +$6.04M $7.00 11
2019 Q4 5.16M $50M +$28.3M $9.69 8
2019 Q3 100K $1.02M +$1.02M $10.15 1